Amaç: Kefirin nonsteroid anti-inflamatuvar ilaç ile peptik ülser hastal›¤› üzerine, kefirin mide mukus bariyerinin miktar› ve et-
INTRODUCTION
Gastric ulceration is related to more than one factor, including Helicobacter pylori (H. pylori) infection, stress, mucosal mucus secretion, gastric irritants, and gastric acidity. It has been claimed for many years that the consumption of kefir, a probiotic fermented milk product, is beneficial for the treatment of gastric and duodenal ulcer. Upon this observation, Evenshtein (1) described in 1978 that the gastric juice was increased by 89% after consumption of kefir for six weeks. It was also demonstrated that kefir reduced H. pylori infection owing to its antibacterial effects in vivo (2, 3) . On the other hand, to the best of our knowledge, the effect of kefir on the gastric mucosal mucus secretion, which may be a factor inducing ulceration, has not been described yet. It is thought that an increase in gastric mucosal secretion might delay or prevent the disease (4) . In the present work, it was intended to evaluate the effect of kefir consumption in an experimental model of acute gastric ulcer, with non-steroid anti-inflammatory drugs (NSAIDs), with determination of gastric mucus secretion by quantitative digital histochemistry.
MATERIALS AND METHODS

Experimental Materials and Animals
The study protocol was approved by the Local Ethics Committee at Dokuz Eylül University Faculty of Medicine. The experimental groups consisted of 28 male albino Wistar rats from Dokuz Eylül University, Medical Science Faculty, Laboratory of the Experimental Animals Department. After a diet with standard rat bait for 7 days, 14 rats were fed with kefir for 7 days while the others were kept on the same diet. At the 14 th day of the experiment, 7 rats fed on kefir and 7 rats fed standard rat bait were given indomethacin injection, and after 4 hours (h) all the rats were sacrificed ( Table 1) .
The rats were weighed on the 1 st , 7 th and 14 th days (5,6).
Production of Kefir
Raw cow's milk supplied from Ege University Agriculture Faculty, Menemen Research and Application Farm, was used in kefir-making. The milk was heated at 90°C for 5 minutes (min), followed by inoculation with the kefir grains provided by Ege University Agriculture Faculty, Dairy Technology Department, Microbiology Laboratory, at a rate of 5% and incubated at 20±3°C until pH 4.7 was attained in glass cups. After incubation, kefir grains were removed by a sterile wire sieve. The filtrate was used as kefir in the rest of the experiment (7).
Raw Milk and Kefir Analysis
In raw milk and kefir, the pH, titratable acidity (expressed as percentage lactic acid), total solids, fat, total nitrogen, ash, and lactose contents were determined according to Turkish Standards Institution Method (8). In the counts of Streptococcus spp., M17 agar (OXOID, CM 785), Lactobacillus spp. MRS agar (OXOID, CM 361) and total yeasts Dichloran Rose Bengal Chloramphenicol (DRBC) agar (CM 727) were used (9) .
Gross Examination
The gastric and duodenal tissues were evaluated by gross examination and scored as follows: 0: no evidence of ulceration, 1: erosion, and 2: ulceration. The gastric and duodenal tissues were formalin-fixed, and for histopathological examination, the gastric wall was sampled, beginning from the cardia-esophageal junction to the duodenum through the lesser curvature, and paraffin-embedded tissue blocks were prepared. The sections from these blocks were stained by hematoxylin and eosin (H&E) and periodic acid-Schiff (PAS) (10) .
Microscopic Evaluation of Gastric Mucosa
Hematoxylin and eosin-stained sections were evaluated for any evidence of erosion or ulceration and scored as follows: 0: no evidence of erosion or ulceration, 1: erosion identified by loss of the superficial layer of mucosa replaced by inflamma- tory cells and/or fibrin, and 2: ulceration with loss of mucosal layer. Additionally, H. pylori was searched in every section (10, 11, 12) . In the sections of the whole gastric mucosa, painted hematoksilen eosin was processed and researched. In those parts there were not gastric erosion and ulceration, but erosion and ulceration was scored to come into ( Fig. 1a -b , 2).
Determination of Gastric Mucus by Quantitative Digital Histochemistry
For a standard measurement of the gastric mucosal mucus, PAS-stained sections from the small curvature were selected for measurement, and images were taken subsequently from the gastroesophageal junction to the duodenum. All the gastric mucosal mucus could thus be quantified at the lesser curvature, excluding the zones with extensive erosion and ulceration, where mucosa could not be observed. Digital images were obtained from the selected areas using light microscopy (Olympus, BX51, Japan) at original magnification of x40. Images were captured by a digital color video camera (Olympus DP70). The stained mucosal areas in the captured images were quantified by measuring the high power fields using a software (Mustafa Sakar, ‹zmir, Turkey). The magenta color was selected; the image analysis program calculated the stained area percentage (SAP), as described previously (11) (12) (13) . On the image when the magenta color was selected, neighbors to that and designated color neighbors were covered by the analysis programme automatically, and was expressed as the proportion of the selected area to the total area ( Fig. 3 a -b ) (12) .
Statistical Evaluation
Statistical evaluation was performed using the Statistical Package for the Social Sciences for
Windows software package (SPSS ver. 11.0 for Windows; Chicago, IL). SPSS version 11.0 was used for statistical analysis and the Mann-Whitney U test for comparisons between groups. The relationship between variables was investigated using Pearson's rank correlation (14) .
RESULTS
The chemical and microbiological properties of raw milk and kefir are summarized in Table 2 .
The average weight of the rats was 188.04±19.66 g, 210.46±21.20 g and 219.39±22.59 g on the 1 st , 7 th and 14 th day, respectively, and there was a significant difference between groups (p<0.000, one way ANOVA). There was a significant difference the first and second as well as between the first and third measurements (p<<0.000 and p<<0.000, Mann-Whitney U test), but there was no significant difference between the second and third measurements (p=0.14, Mann-Whitney U test). When the body masses of groups on standard diet and those receiving kefir were compared, no significant difference was noted in the last two measurements (p=0.10 and p=0.19, respectively). Gross and microscopic examinations did not reveal erosion or ulceration for the cases that did not receive indomethacin. There was erosion in 4 (57%) and ulceration in 3 (43%) of the cases fed on standard diet, while erosion was identified in 6 (86%) and ulceration in 1 (14%) of the cases receiving kefir ( Table 3 ). There was no significant difference between the groups (p=0.25, Mann-Whitney U test).
Raw milk Kefir
The average SAP for all cases was 5.09±2.64% (range: 0.99-12-10%). The mean SAP for cases receiving standard diet and kefir diet, but not indomethacin, was 6.40±2.94 and 5.90±3.15, respectively, and for the groups receiving indomethacin, these values were 4.65±1.55 and 3.75±2.5 (Table  3 ). There was no significant difference between the groups (p=0.313, Kruskal-Wallis test). Overall, when the 14 cases on standard diet were compared with the cases on kefir diet, there was no significant difference between the groups in terms of SAP values (p=0.32).
DISCUSSION
Peptic ulcer disease is a result of the loss of balance between gastric mucosal protection and gastric acidity. The mucus layer spares the gastric mucosal surface and pit epithelium from the digestive effect of the gastric juice.
The leading etiologic factor for the development of peptic ulcer disease, as well as of gastric carcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma is H. pylori infection. The bacteria act on the 1500 proteins, which induces epithelial cell apoptosis, metaplasia, atrophy, dysplasia, and carcinoma, as well as ulceration following multiple pathways. The latter is located at the duodenum predominantly, in the setting of antral H. pylori infection, with increased gastric acidity and gastric metaplasia of the duodenal mucosa (15) . Many drugs as well as natural products have been evaluated for the eradication of H. pylori since the identification by Marshall and Warren and Lichtenberger et al. (16, 24) .
Researches on fermented milk and probiotics have proven the health benefits of these products. Kefir is a probiotic fermented milk product originating from the Caucasian mountains. It is a cultured milk, in which both acid and alcohol fermentation is developed. Kefir has a refreshing and slightly sharp taste and aroma. The original starter of kefir is also called kefir grain. Kefir grain, resembling florets of a cauliflower, are white-yellowish in color, 2 to 4 mm in diameter. The surface of the grain is rough and convoluted. They are held together in clusters as an immobilized system of a complex community of yeast and bacterial cells embedded in a microbe-produced polysaccharide matrix along with some milk fat and denatured milk protein (7, 17 (3, (18) (19) (20) .
Kefir and other fermented probiotics milk products may have an antibacterial effect on H. pylori infection (3, 21) . On the other hand, there is no satisfactory data about the effect of kefir on other mechanisms, which may contribute to the progression of the available milieu for the development of peptic ulcer. The second most frequent factor for the development of peptic ulcer disease is NSAIDs. They induce gastric injury by intracellular accumulation and inhibition of prostaglandin synthesis (22, 23) . NSAIDs also reduce the hydrophobicity of the mucus gel layer by an insult to the surface-active phospholipids. It has been shown that this can be prevented by pre-associating a NSAID with zwitterionic phospholipids (24) .
The present study is based on the hypothesis that kefir may have other effects on the gastric milieu in addition to its antibacterial properties. The experimental model depends upon consumption of kefir with suitable properties. In Table 2 , the analysis results of the kefir, which were only for 1-2 days, were in agreement with the findings of other researchers regarding the general composition and microbiologic appearance of kefir; especially from the perspective of probiotic effect, Lactobacillus and Streptococcus genus showed that they were of sufficient degree considering the number (5, (25) (26) (27) . The gross composition of raw milk used in the production of kefir was close to the average milk composition (1, 3, 7, 17, 26, 27 ).
The experimental model questions the effect of kefir consumption on the prevention of NSAID-induced peptic ulcer, and if positive results were obtained, this would lead to a series of new questions about the mechanism. We did not find a statistically significant difference between groups on rat bait and kefir considering lesions of erosion and ulceration, but the number of cases with ulceration was more for cases that did not receive kefir. This finding may deserve evaluation in a larger number of cases, as the statistically insignificant results may have been caused by the low number of cases in this series.
The increase in the amount of mucus secretion may reduce the NSAIDs ulcerogenic effect on the gastric mucosa (28) . The amount of gastric mucus was quantified by image analysis based on PAS histochemistry. There was no significant difference between the group on the kefir diet and the group on the standard rat bait (p>0.05).
The results of the present study argue against the role of kefir consumption on prevention of NSAIDinduced gastric ulceration by increasing gastric mucus. As the number of cases with ulceration was less in cases on kefir in this series, the effects of kefir on indomethacin-induced gastric injury might be evaluated in larger series with the other mucosa-saving effects of kefir, like prostaglandin E2 secretion, which is suggested as a mechanism for decreasing alcohol-induced injury (29) .
